This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe.
magazine.eacr.org/congratulati...
And a happy coincidence that all three awardees are women scientists in the labs of three women PIs 🙌
#WomeninSTEM #WomeninScience 👩🔬👩🏻🔬🧪
@themarkfdn.bsky.social
@helloeacr.bsky.social
@juliemmazet.bsky.social
This funding is awarded for a period of three years to support excellent postdoctoral researchers in laboratories throughout Europe.
magazine.eacr.org/congratulati...
And a happy coincidence that all three awardees are women scientists in the labs of three women PIs 🙌
#WomeninSTEM #WomeninScience 👩🔬👩🏻🔬🧪
@themarkfdn.bsky.social
@helloeacr.bsky.social
@juliemmazet.bsky.social
🎯 EiC: @haanenjohn.bsky.social
Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...
If you are presenting your work at #ESMOImmuno24, and potentially looking for a home for your research work, please consider submitting to our ESMO IOTECH journal:
🔗 esmoiotech.org
🎯 EiC: @haanenjohn.bsky.social
Section Editors:
@michalbassani.bsky.social (NeoAg/TILs)
@danielathommen.bsky.social (Biomarkers/novel IO targets)...
🔴 Heterogeneity in data, samples and assay types
🧬 Need for cross-study harmonisation & tailored composite biomarkers
💊 Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!
🔴 Heterogeneity in data, samples and assay types
🧬 Need for cross-study harmonisation & tailored composite biomarkers
💊 Neoadj. trials & PDTF’s offer opportunities for biomarker discovery!